Literature DB >> 24231618

A peptide's perspective on antigen presentation to the immune system.

Jacques Neefjes1, Huib Ovaa.   

Abstract

Specific immune responses are critically dependent on protein degradation products in the form of peptides. These peptides are presented by major histocompatibility complexes (MHCs), and recognition of MHC-peptide complexes by the immune system determines successful pathogen elimination, transplant rejection, autoimmunity or death. Here we review the immune response from the peptide's perspective and discuss the fate of peptides in cells before presentation by MHC complexes. We then discuss how peptides are altered post-translationally to yield immune responses and how peptides can be engineered to achieve strong immune responses following vaccination. Although peptides are simple from a chemical perspective, they are complex in their immunological consequences.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24231618     DOI: 10.1038/nchembio.1391

Source DB:  PubMed          Journal:  Nat Chem Biol        ISSN: 1552-4450            Impact factor:   15.040


  68 in total

1.  Presentation of cytosolic glycosylated peptides by human class I major histocompatibility complex molecules in vivo.

Authors:  J S Haurum; I B Høier; G Arsequell; A Neisig; G Valencia; J Zeuthen; J Neefjes; T Elliott
Journal:  J Exp Med       Date:  1999-07-05       Impact factor: 14.307

2.  A critical role for tapasin in the assembly and function of multimeric MHC class I-TAP complexes.

Authors:  B Ortmann; J Copeman; P J Lehner; B Sadasivan; J A Herberg; A G Grandea; S R Riddell; R Tampé; T Spies; J Trowsdale; P Cresswell
Journal:  Science       Date:  1997-08-29       Impact factor: 47.728

3.  A major role for TPPII in trimming proteasomal degradation products for MHC class I antigen presentation.

Authors:  Eric Reits; Joost Neijssen; Carla Herberts; Willemien Benckhuijsen; Lennert Janssen; Jan Wouter Drijfhout; Jacques Neefjes
Journal:  Immunity       Date:  2004-04       Impact factor: 31.745

Review 4.  Towards a systems understanding of MHC class I and MHC class II antigen presentation.

Authors:  Jacques Neefjes; Marlieke L M Jongsma; Petra Paul; Oddmund Bakke
Journal:  Nat Rev Immunol       Date:  2011-11-11       Impact factor: 53.106

Review 5.  Genomics and the multifactorial nature of human autoimmune disease.

Authors:  Judy H Cho; Peter K Gregersen
Journal:  N Engl J Med       Date:  2011-10-27       Impact factor: 91.245

6.  The 1995 Albert Lasker Medical Research Award. The class I and class II proteins of the human major histocompatibility complex.

Authors:  J L Strominger; D C Wiley
Journal:  JAMA       Date:  1995-10-04       Impact factor: 56.272

Review 7.  Protein-peptide interactions.

Authors:  R L Stanfield; I A Wilson
Journal:  Curr Opin Struct Biol       Date:  1995-02       Impact factor: 6.809

8.  Probing molecular interactions within class II MHC Aq/glycopeptide/T-cell receptor complexes associated with collagen-induced arthritis.

Authors:  Ida E Andersson; Balik Dzhambazov; Rikard Holmdahl; Anna Linusson; Jan Kihlberg
Journal:  J Med Chem       Date:  2007-10-18       Impact factor: 7.446

9.  Identification of beryllium-dependent peptides recognized by CD4+ T cells in chronic beryllium disease.

Authors:  Michael T Falta; Clemencia Pinilla; Douglas G Mack; Alex N Tinega; Frances Crawford; Marc Giulianotti; Radleigh Santos; Gina M Clayton; Yuxiao Wang; Xuewu Zhang; Lisa A Maier; Philippa Marrack; John W Kappler; Andrew P Fontenot
Journal:  J Exp Med       Date:  2013-07-01       Impact factor: 14.307

Review 10.  Nomenclature and listing of celiac disease relevant gluten T-cell epitopes restricted by HLA-DQ molecules.

Authors:  Ludvig M Sollid; Shuo-Wang Qiao; Robert P Anderson; Carmen Gianfrani; Frits Koning
Journal:  Immunogenetics       Date:  2012-02-10       Impact factor: 2.846

View more
  31 in total

1.  Stabilization of exosome-targeting peptides via engineered glycosylation.

Authors:  Michelle E Hung; Joshua N Leonard
Journal:  J Biol Chem       Date:  2015-02-05       Impact factor: 5.157

2.  Caveolin-mediated endocytosis of the Chlamydia M278 outer membrane peptide encapsulated in poly(lactic acid)-Poly(ethylene glycol) nanoparticles by mouse primary dendritic cells enhances specific immune effectors mediated by MHC class II and CD4+ T cells.

Authors:  Saurabh Dixit; Rajnish Sahu; Richa Verma; Skyla Duncan; Guillermo H Giambartolomei; Shree R Singh; Vida A Dennis
Journal:  Biomaterials       Date:  2017-12-26       Impact factor: 12.479

Review 3.  Molecular pathways for antigenic peptide generation by ER aminopeptidase 1.

Authors:  Anastasia Mpakali; Zachary Maben; Lawrence J Stern; Efstratios Stratikos
Journal:  Mol Immunol       Date:  2018-04-17       Impact factor: 4.407

4.  Reduction Sensitive PEG Hydrogels for Codelivery of Antigen and Adjuvant To Induce Potent CTLs.

Authors:  Chintan H Kapadia; Shaomin Tian; Jillian L Perry; J Christopher Luft; Joseph M DeSimone
Journal:  Mol Pharm       Date:  2016-09-22       Impact factor: 4.939

5.  The Activated AMPK/mTORC2 Signaling Pathway Associated with Oxidative Stress in Seminal Plasma Contributes to Idiopathic Asthenozoospermia.

Authors:  Nannan Cao; Chunhui Hu; Bintong Xia; Yan He; Jiaolong Huang; Zhicheng Yuan; Jie Deng; Peng Duan
Journal:  Oxid Med Cell Longev       Date:  2022-06-08       Impact factor: 7.310

Review 6.  Rational Vaccinology: Harnessing Nanoscale Chemical Design for Cancer Immunotherapy.

Authors:  Ziyin Huang; Cassandra E Callmann; Shuya Wang; Matthew K Vasher; Michael Evangelopoulos; Sarah Hurst Petrosko; Chad A Mirkin
Journal:  ACS Cent Sci       Date:  2022-05-20       Impact factor: 18.728

7.  The double-edged sword of cancer mutations: exploiting neoepitopes for the fight against cancer.

Authors:  Isabel Alvarado-Cruz; Rithy Meas; Sesha Lakshmi Arathi Paluri; Kelly Estelle Wheeler Carufe; Mohammed Khan; Joann Balazs Sweasy
Journal:  Mutagenesis       Date:  2020-02-13       Impact factor: 3.000

8.  Precancer Atlas to Drive Precision Prevention Trials.

Authors:  Avrum Spira; Matthew B Yurgelun; Ludmil Alexandrov; Anjana Rao; Rafael Bejar; Kornelia Polyak; Marios Giannakis; Ali Shilatifard; Olivera J Finn; Madhav Dhodapkar; Neil E Kay; Esteban Braggio; Eduardo Vilar; Sarah A Mazzilli; Timothy R Rebbeck; Judy E Garber; Victor E Velculescu; Mary L Disis; Douglas C Wallace; Scott M Lippman
Journal:  Cancer Res       Date:  2017-04-01       Impact factor: 13.312

9.  Replication-Competent Foamy Virus Vaccine Vectors as Novel Epitope Scaffolds for Immunotherapy.

Authors:  Janet Lei; Wolfram Osen; Adriane Gardyan; Agnes Hotz-Wagenblatt; Guochao Wei; Lutz Gissmann; Stefan Eichmüller; Martin Löchelt
Journal:  PLoS One       Date:  2015-09-23       Impact factor: 3.240

10.  The T cell differentiation landscape is shaped by tumour mutations in lung cancer.

Authors:  Ehsan Ghorani; James L Reading; Jake Y Henry; Marc Robert de Massy; Rachel Rosenthal; Virginia Turati; Kroopa Joshi; Andrew J S Furness; Assma Ben Aissa; Sunil Kumar Saini; Sofie Ramskov; Andrew Georgiou; Mariana Werner Sunderland; Yien Ning Sophia Wong; Maria Vila De Mucha; William Day; Felipe Galvez-Cancino; Pablo D Becker; Imran Uddin; Theres Oakes; Mazlina Ismail; Tahel Ronel; Annemarie Woolston; Mariam Jamal-Hanjani; Selvaraju Veeriah; Nicolai J Birkbak; Gareth A Wilson; Kevin Litchfield; Lucia Conde; José Afonso Guerra-Assunção; Kevin Blighe; Dhruva Biswas; Roberto Salgado; Tom Lund; Maise Al Bakir; David A Moore; Crispin T Hiley; Sherene Loi; Yuxin Sun; Yinyin Yuan; Khalid AbdulJabbar; Samra Turajilic; Javier Herrero; Tariq Enver; Sine R Hadrup; Allan Hackshaw; Karl S Peggs; Nicholas McGranahan; Benny Chain; Charles Swanton; Sergio A Quezada
Journal:  Nat Cancer       Date:  2020-05-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.